Burkholderia cepacia complex in cystic fibrosis in the post-epidemic period: multilocus sequence typing-based approach

. 2017 Nov ; 62 (6) : 509-514. [epub] 20170331

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid28364392
Odkazy

PubMed 28364392
DOI 10.1007/s12223-017-0523-x
PII: 10.1007/s12223-017-0523-x
Knihovny.cz E-zdroje

Cystic fibrosis (CF) patients in the Czech Republic suffered in the late 1990s from an epidemic with ST32 strain of Burkholderia cepacia complex (Bcc). Cohort segregation of Bcc and of ST32 positive patients was introduced in 1999 and 2002, respectively. We performed a study to evaluate the molecular epidemiology of Bcc infection after implementation of these infection control measures. Patients attending the Prague CF adult Centre from 2000 to 2015 were included in the present study. Demographic data and microbial statuses were collected from patient records. All Bcc isolates were analyzed using multilocus sequence typing (MLST). The prevalences of epidemic strain ST32 and of other Bcc strains were calculated. Ninety out of 227 CF patients were infected with Bcc during the study period. The prevalence of ST32 cases significantly decreased from 46.5% in 2000-2001 to 10.4% in 2014-2015 (P < 0.001) due to occurrence of only one new case in 2003, as well as to the death of 72% of ST32-infected patients. Conversely, there was a significant increase in prevalence of other Bcc strains, which rose from 0 to 14.9% (P = 0.015) and of transient infections. A micro-epidemic of infection with ST630 strain was observed in 2014 in lung transplant patients hospitalized in intensive care unit. The prevalence of epidemic strain ST32 decreased, whereas that of non-clonal strains of Bcc increased. Routine use of MLST allowed early detection of new and potentially epidemic strains.

Zobrazit více v PubMed

Infect Control Hosp Epidemiol. 2014 Aug;35 Suppl 1:S1-S67 PubMed

J Clin Microbiol. 1994 Apr;32(4):924-30 PubMed

J Clin Microbiol. 2005 Sep;43(9):4665-73 PubMed

J Clin Microbiol. 2001 Aug;39(8):2891-6 PubMed

J Pediatr. 1998 Apr;132(4):589-95 PubMed

J Med Microbiol. 2005 Jul;54(Pt 7):655-9 PubMed

J Clin Microbiol. 2007 May;45(5):1628-33 PubMed

J Appl Microbiol. 2008 Jun;104(6):1539-51 PubMed

J Med Microbiol. 2003 Jul;52(Pt 7):603-4 PubMed

J Clin Microbiol. 2013 Jan;51(1):339-44 PubMed

J Cyst Fibros. 2012 Sep;11(5):440-5 PubMed

Lancet. 1993 Jul 3;342(8862):15-9 PubMed

J Clin Microbiol. 2010 Aug;48(8):2981-3 PubMed

Lancet. 1990 Nov 3;336(8723):1094-6 PubMed

Clin Microbiol Infect. 2010 Jul;16(7):821-30 PubMed

J Microbiol Methods. 2008 Oct;75(2):279-86 PubMed

J Cyst Fibros. 2007 May;6(3):215-9 PubMed

Chest. 2000 Jun;117(6):1661-5 PubMed

Eur J Epidemiol. 1987 Dec;3(4):336-42 PubMed

J Clin Microbiol. 2004 Apr;42(4):1491-7 PubMed

J Pediatr. 2001 Nov;139(5):643-9 PubMed

J R Soc Med. 2003;96 Suppl 43:66-72 PubMed

Lancet. 2003 Feb 22;361(9358):681-9 PubMed

Ann Am Thorac Soc. 2015 Jan;12(1):70-8 PubMed

J Pediatr. 1984 Feb;104(2):206-10 PubMed

J Hosp Infect. 2013 Jul;84(3):248-51 PubMed

Clin Infect Dis. 2003 Sep 15;37(6):780-5 PubMed

Clin Microbiol Infect. 2015 Feb;21(2):150-6 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...